OptimizeRx Extends Omnichannel Reach With Cooler Screens Partnership
“We are opening new channels of direct patient engagement with Cooler Screens,” noted
Cooler Screens is currently present in 28 geographical markets nationally with more than 10,000 screens in retail stores and more than 90 million in monthly traffic. Cooler Screens has deployed their in-store digital media ad-platform at more than 700 retail locations nationwide, including Walgreens, CVS, and Kroger.
The technology provides relevant digital content to consumers on retail surfaces including the doors of coolers in the refrigerated and frozen food sections of a variety of retailers with pharmacies that have enabled the platform.
“Our innovative digital media platform in combination with OptimizeRx’s comprehensive suite of healthcare-specific digital touchpoints serves as a novel and impactful offering for their ad agency clients,” said
According to a survey conducted by
About Cooler Screens
Cooler Screens is creating the world's largest in-store digital media and merchandising platform for retail. We transform retail surfaces into digital IoT smart screens that deliver in-store retail media and merchandising for the ultimate consumer experience at the intersection of commerce, context, and content. With 90% of food, beverage and health category purchases still taking place in physical stores, Cooler Screens enable retailers to quantify and improve consumer experiences and allow brands to drive sales and build brand equity by connecting with consumers at the first moment of truth. Retail partners span grocery, drug and convenience stores, including Walgreens, Kroger, Giant Eagle,
Important Cautions Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or other similar words and expressions are intended to identify these forward-looking statements. All statements that reflect the Company’s expectations, assumptions, projections, beliefs, or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the Company’s growth, business plans, and future performance. These forward-looking statements are based on the Company’s current expectations and assumptions regarding the Company’s business, the economy, and other future conditions. The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by applicable law. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other risks summarized in the Company’s Annual Report on Form 10-K for the fiscal year ended
Andy D’Silva, SVP Corporate Finance
Media Relations Contact
Investor Relations Contact
Source: OptimizeRx Corporation